Prevalence of acne vulgaris in patients with down syndrome

Dermatology

Volumn 220, Issue 4, 2010, Pages 333-339

  Bagatin, Edileia ^a,d   Kamamoto, Cristhine Souza Leão ^a   Dos Santos Guadanhim, Lilia Ramos ^a   Sanudo, Adriana ^b   Costa Dias, Marilia ^c   Barraviera, Isa Mara ^c   Consolim Colombo, Fernanda ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Associação de Pais e Amigos Dos Excepcionais   (Brazil)

^d Universidade de São Paulo ^*  (Brazil)

Author keywords

Acne vulgaris; Down syndrome; Obesity

Indexed keywords

ANTICONVULSIVE AGENT;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOWN SYNDROME; ENDOCRINE DISEASE; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HUMAN; HYPERANDROGENISM; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SKIN COLOR; BRAZIL; METABOLIC DISEASES; YOUNG ADULT;

ACNE VULGARIS; ADOLESCENT; ADULT; BRAZIL; CHILD; CROSS-SECTIONAL STUDIES; DOWN SYNDROME; FEMALE; HUMANS; HYPERANDROGENISM; MALE; METABOLIC DISEASES; OBESITY; PREVALENCE; YOUNG ADULT;

EID: 77954243972     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000284680     Document Type: Article

References (39)

1. Zouboulis CC: Acne and sebaceous gland function. Clin Dermatol 2004; 22: 360-366.
2. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WJ, Rosenfield R: What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-152.
3. Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, Xia L, Chen W, Nagy I, Picardo M, Suh DH, Ganceviciene R, Schagen S, Tsatsou F, Zouboulis CC: New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009; 18: 821-832.
4. Zouboulis CC, Böhm M: Neuroendocrine regulation of sebocytes - a pathogenetic link between stress and acne. Exp Dermatol 2004; 13(suppl 4):31-35.
5. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR: Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 2002; 99: 7148-7153.
6. Ghodsi SZ, Orawa H, Zouboulis CC: Prevalence, severity and severity risk factors of acne in high school pupils: a communitybased study. J Invest Dermatol 2009; 129: 2136-2141.
7. Rademaker M, Garioch JJ, Simpson NB: Acne in school children: no longer a concern for dermatologists. Br Med J 1989; 298: 1217-1219.
8. Orfanos CE, Adler YD, Zouboulis CC: The SAHA syndrome. Horm Res 2000; 54: 251-258.
9. Yarak S, Bagatin E, Hassun KM, et al: Hyperandrogenism and skin: polycystic ovarian syndrome and insulin resistance. An Bras Dermatol 2005; 80: 395-410.
10. Strauss JS, Krowchuk DP, Leyden JJ: Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651-663.
11. Daniel D, Dreno B, Poli F, et al: Epidemiologie descriptive de l'acné dans la population scolarisée en France métropolitaine pédant l'automne 1996. Ann Dermatol Venereol 2000; 127: 273-278.
12. Schafer T, Nienhaus A, Vieluf D, et al: Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145: 100-104.
13. Jemec GBE, Linneberg A, Nielsen NH, et al: Have oral contraceptives reduced the prevalence of acne? A population-based study of acne vulgaris, tobacco smoking and oral contraceptives. Dermatology 2002; 204: 179-184.
14. Taylor SC, Cook-Bolden F, Rahman Z, Strachan D: Acne vulgaris in skin color. J Am Acad Dermatol 2002; 46:S98-S106.
15. Gollnick H, Cunliffe W, Berson D, et al: Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49(1 suppl):S1-S37.
16. Dourmishev A, Miteva L, Mitev V, et al: Cutaneous aspects of DS. Cutis 2000; 66: 420-424.
17. Barankin B, Guenther L: Dermatological manifestations of Down's syndrome. J Cutan Med Surg 2001; 5: 289-293.
18. Schepis C, Barone C, Siragusa M, et al: An updated survey on skin conditions in DS. Dermatology 2002; 205: 234-238.
19. Madan V, Williams J, Lear JT: Dermatological manifestations of Down's syndrome. Clin Exp Dermatol 2006; 31: 623-639.
20. Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M: Mucocutaneous findings in 100 children with DS. Pediatr Dermatol 2007; 24: 317-320.
21. Melville CA, Cooper SA, McGrother CW, et al: Obesity in adults with DS: a case-control study. J Intellect Disabil Res 2005; 49: 125-133.
22. Grammatikopoulou MG, Manai A, Tsigga M, et al: Nutrient intake and anthropometry in children and adolescents with DS - preliminary study. Dev Neurorehabil 2008; 11: 260-267.
23. Ordonez FJ, Rosety M, Rosety-Rodriguez M: Influence of 12-week exercise training on fat mass percentage in adolescents with DS. Med Sci Monit 2006; 12:CR416-CR419.
24. Whitt-Glover MC, O'Neill KL, Stettler N: Physical activity in children with and without DS. Pediatr Rehabil 2006; 9: 158-164.
25. Magge SN, O'Neill KL, Shults J, et al: Leptin levels among prepubertal children with DS compared with their siblings. J Pediatr 2008; 152: 321-326.
26. Essah PA, Nestler JE: The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest 2006; 29: 270-280.
27. Sarkany RPE, Breathnach SM, Seymour CA, et al: Metabolic and nutritional disorders; in Burns T, Breathnach SM, Cox N, Griffiths C (eds): Rook's Textbook of Dermatology. Oxford, Blackwell Science, 2004, pp 57.1-57.124.
28. Gisondi P, Tessari G, Conti A, et al: Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.
29. Ribera M, Pinto X, Argimon JM, et al: Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma. Am J Med 1995; 99: 485-490.
30. Goulden V, Stables GI, Cunliffe WJ: Prevalence of facial acne in adults. J Am Acad Dermatol 1999; 41: 577-580.
31. Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007; 356: 213-215.
32. Wang Y, Monteiro C, Popkin BM: Trends of obesity and underweight in older children and adolescents in the United States, Brazil, China and Russia. Am J Clin Nutr 2002; 75: 971-977.
33. Carmina E, Rosato F, Janni A, et al: Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006; 91: 2-6.
34. Collier CN, Harper JC, Cantrell WC, et al: The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58: 56-59.
35. Karrer-Voegeli S, Rey F, Reymond MJ, et al: Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism. Medicine (Baltimore) 2009; 88: 32-45.
36. Harper JC: Evaluating hyperandrogenism: a challenge in acne management. J Drugs Dermatol 2008; 7: 527-530.
37. Smith R, Mann N, Makelainen H, et al: A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol Nutr Food Res 2008; 52: 718-726.
38. Adebamowo CA, Spiegelman D, Berkey CS, et al: Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008; 58: 787-793.
39. Melnik BC, Schmitz G: Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol 2009; 18: 833-841.